[ad_1]
rewrite this content and keep HTML tags
TODAY: Gillaspie cleared waivers and was outrighted to Triple-A El Paso earlier this week, the Padres announced. Gillaspie made the start for El Paso in yesterday’s game.
JUNE 30: The Padres announced Monday that they’ve reinstated right-hander Logan Gillaspie from the 15-day injured list. Rather than add the out-of-options righty back to the active roster, San Diego has designated him for assignment.
Gillaspie, 28, has been out since late April due to an oblique injury. He appeared in three games for the Friars in 2025, tossing seven innings and holding opponents to just two runs. He did so with matching 12.9% strikeout and walk rates, however, and gave up quite a bit of loud contact along the way (92.1 mph average exit velocity, 45.5% hard-hit rate).
This is the fourth straight season in which Gillaspie has logged at least some big league time. He’s pitched a total of 44 2/3 MLB frames between the Orioles and Padres, logging a combined 4.63 earned run average with a 14.5% strikeout rate, 6% walk rate and 35.7% ground-ball rate. Gillaspie has averaged 95.1 mph on his four-seamer in his career (94.7 mph in 2025) and typically pairs the pitch with an 83-84 mph slider, an 87-88 mph changeup and an 82-83 mph curveball (in descending order of use). At least in his brief three-inning look this year, he’d also begun to mix in a cutter that sat 91.5 mph.
Gillaspie has worked exclusively as a reliever ever since reaching High-A. Originally signed by the Brewers as an undrafted free agent, he’s now pitched in in four Triple-A seasons as well, logging a 4.37 ERA, 23.3% strikeout rate and 8.1% walk rate in 129 2/3 innings. The Padres can trade Gillaspie or place him on waivers at any point in the next five days. Waivers are a 48-hour process, so his DFA will be resolved within a week’s time. Since Gillaspie has never been outrighted and doesn’t have three years of big league service, he’ll stick with the organization as a depth arm in Triple-A if he passes through waivers unclaimed.
[ad_2]
Source link
